Braze's (BRZE) near-certain market-implied odds of beating Q2 fiscal 2027 earnings reflect its consistent track record of outperformance, with 16 beats in the prior 19 quarters, alongside 26% year-over-year revenue growth to $227.2 million and non-GAAP EPS of $0.19 that exceeded consensus estimates around $0.15–0.16. Strong dollar-based net retention at 110%, accelerating enterprise expansion, and AI-driven product momentum have supported raised full-year guidance for revenue near $910–913 million and adjusted EPS of $0.64–0.65. Traders price in these fundamentals through skin-in-the-game consensus, though tail risks such as unexpected macroeconomic pressure on customer spending or a narrower-than-expected beat on margins could still influence resolution.